Vertex Advances Program Targeting Alpha-1 Antitrypsin Deficiency
Go back to Vertex Advances Program Targeting Alpha-1 Antitrypsin Deficiency| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 476.24 -5.76 (1.2%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $482.00 | 52 Week High | $134.71 | |||
| Open | $482.32 | 52 Week Low | $73.31 | |||
| Day High | $483.66 | P/E | N/A | |||
| Day Low | $474.74 | EPS | $-1.98 | |||
| Volume | 130,369 | |||||
